Skip to main content

Why Customers Love Creative Biolabs’ Recombinant Antibodies?

 

Creative Biolabs is a leader in discovering and manufacturing recombinant antibodies. Its products and services propel research in the field of life sciences, solve challenges encountered in experiments, promote the development of medical diagnostics, and improve laboratory productivity.

 

Recombinant Antibodies developed by Creative Biolabs are inspired by its advanced research tools, professional team, and consistent dedication.

 

About recombinant antibodies (rAbs)

 

Taking advantage of the structure of conventional antibodies, rAbs are generated by synthetic genes and occur in vitro. Traditional monoclonal antibodies (mAbs) use B-cells to form hybridomas and produce the desired antibody clone. Different from the former, recombinant antibodies production code antibody genes into high-yield expression vectors. These vectors need to be introduced into bacteria, yeast, or other expression hosts to generate rAbs instead of using hybridomas and animals in the production process.

 

Recombinant antibody production outperforms traditional mAbs in many ways. It overcomes previous technical limitations, showing noticeable batches consistency, reproducibility, scalability, specificity with confirmed long-term supply.

 

rAbs can normally replace the traditional mAbs in most cases, such as biomedical science and toxicological research, without causing pain and discomfort to the animals.

 

Advantages of Creative Biolabs’ Recombinant Antibodies

 

Creative Biolabs delivers a variety of recombinant antibodies for researchers with commendable features.

 

Competitive ability to reproduce and control

Extraordinary specificity and sensitivity

Isotype conversion

Cost-effective process

Decreased production time

 

The recombinant antibody products of Creative Biolabs return powerful and positive signals and can be reproduced for several months in the host body. Covering thousands of genes and a wide range of applications, Creative Biolabs has developed different rAbs hosted by humans, goat, chicken, Armenian hamster, rat, sheep, rabbit, mouse, cattle, chimeric, Guinea pig, alpaca, etc.

 

These products allow researchers to isolate antibodies against antigens or antigen characteristics easily and take control of experimental conditions. Creative Biolabs develops recombinant antibodies to significantly shorten the experimental time and eliminate the ethical and animal welfare concerns for researchers.

 

As it was known, an antibody is structured with two heavy chains (VH) and two light chains (VL). Recombinant antibodies production clone the variable genes on heavy and light chains through PCR and design the required primers. Then experts at Creative Biolabs get highly efficient transformation with competent sources. Their advanced display technology will guarantee the reconstructed antibody expressions within large-scale production.

 

Besides, Creative Biolabs believes that a model of custom-service-centered business will optimize the drug research and development process. Therefore, based on the principle of producing recombinant antibodies, the team is glad to customize services and products for scientists with special project needs.

 

The Application of Recombinant Antibodies

 

Recombinant antibodies now have been long established in the use of research and treatments for cancer, autoimmune disorders, and other diseases because these antibody fragments can:

 

Shorten circulating half-life in serum

Distribute to broader tissue and penetrate tumors

Reduce cost and increase manufacturing scale

Form bispecific antibody fragments and other desired molecules.

 

Smaller size, easier engineering and manufacture process, and high tissue penetration, all these advantages grant recombinant antibodies a greater chance of success.

 

Creative Biolabs devotes all passions to engineering and manufacturing antibodies with extensive experience. Decades of efforts have merged into trustworthy antibody services and products. If you are interested in more recombinant antibody products or need help with your projects, please don’t hesitate to contact us.

 

 

Comments

Popular posts from this blog

Everything You Want to Know About Antibody Development

  Everything You Want to Know About Antibody Development   When foreign molecules, which are known as antigens, enter our body, antibodies will be released by B cells of the immune system to specifically bind to the antigens and finally clear out those “invaders”. Such a highly specific molecular recognition mechanism has inspired a variety of antibody development research and diagnostic applications nowadays, including IVD antibody development .   What is Antibody Development?   Antibody development is the process of creating and characterizing an antibody.   The timeline of developing antibodies starts from the injection of an antigen of interest into a host animal, so that the host’s immune system can detect it and generat e  the desired antibodies. Then, antibody development proceeds with finding and isolating the desired antibodies from the rest of the protein in sera.   The reset procedure of antibody development is varied as the desired antibodi...

An Overview of the Global Bispecific Antibody Therapeutics Market

  Antibod ies , a major component of adaptive immunity, play a critical role in protective and pathogenic immune responses. In r ecent years, a wide range of antibodies is discovered as candidates of cancer therapeutic agents, including the reconstructive molecules, bispecific antibodies (BsAbs).   About Bispecific Antibody   Bispecific antibodies, as its name indicates, consists of two antigen-binding sites, which can simultaneously bind two separate and unique antigens (or different epitopes of the same antigen). This structure is  typically designed to bind to two targets, one on a cancer cell and one on an immune cell, act ivating or redirecting immune effector cells with the goal of getting the immune cell to kill the cancer cell by antibody-dependent cell-mediated cytotoxicity (ADCC), antibody-dependent cellular phagocytosis (ADCP), complement-dependent cytotoxicity (CDC) and other cytotoxic mechanisms.   U nique biological and pharmacological properties, ...

Unmodified Bacteriophages Research Updates

  R ecent research conducted by researchers from Yale University is published in  Applied and Environmental Microbiology , suggesting  that natural bacteriophage, or phage, can kill dysentery-causing bacteria and reduce virulence in surviving bacteria. It's a piece   of  inspiring news as  treating dysentery has become a challenge with the rising antibiotic resistance.   Background   Shigella flexneri , the culprit causing contagious infection marked by inflammatory diarrhea and dysentery in sub-Saharan Africa and southern Asia, kills about 160,000 people globally every year. The World Health Organization (WHO) takes priority to this pathogen in terms of increasing cases, antimicrobial resistance, and limited treatment options.   S. flexneri  is active primarily in low-income countries, like southern Asia and sub-Saharan Africa. In these places, dirty drinking water is a concern causing dysentery, while antibiotics are expensive and unav...